Navidea Biopharmaceuticals Inc (NAVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAVB | TMO | ISRG | EW | DXCM |
| Company | Navidea Biopharmaceuticals Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.0360 | 555.86 | 378.93 | 89.89 | 136.07 |
| High | 0.0479 | 556.00 | 379.71 | 89.89 | 136.64 |
| Low | 0.0360 | 546.45 | 371.14 | 86.45 | 132.88 |
| Last | 0.0420 | 547.25 | 374.17 | 87.24 | 133.86 |
| Change | +0.0078 | -7.30 | -4.38 | -2.81 | -2.66 |
| % Change | +22.81% | -1.32% | -1.16% | -3.12% | -1.95% |
| Volume | 12,100 | 1,610,000 | 1,625,600 | 2,878,100 | 3,222,400 |
| 20-Day Average Volume | 61,710 | 1,193,980 | 1,375,875 | 3,026,215 | 2,436,955 |
| Previous Close | 0.0342 | 554.55 | 378.55 | 90.05 | 136.52 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0401 | 573.32 | 388.32 | 92.47 | 137.21 |
| 20-Day Raw Stochastic | 33.33% | 1.84% | 9.29% | 8.17% | 23.85% |
| 20-Day Relative Strength | 50.68% | 39.21% | 43.72% | 43.79% | 51.31% |
| Weighted Alpha | -60.51 | -0.83 | +26.34 | +6.57 | +16.77 |
| Today's Opinion | 56% Sell | 40% Buy | 56% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 96% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.53% since 04/10/24 | -4.61% since 04/10/24 | -3.68% since 04/10/24 | -4.67% since 04/10/24 | -4.60% since 04/10/24 |
| Low | 0.0330 on 04/12/24 | 546.45 on 04/17/24 | 371.14 on 04/17/24 | 86.45 on 04/17/24 | 132.88 on 04/17/24 |
| High | 0.0600 on 04/15/24 | 580.35 on 04/11/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 141.25 on 04/11/24 |
| 1-Month | |||||
| %Chg | +13.21% since 03/15/24 | -6.32% since 03/15/24 | -5.58% since 03/15/24 | -5.49% since 03/15/24 | +2.61% since 03/15/24 |
| Low | 0.0330 on 04/12/24 | 546.45 on 04/17/24 | 371.14 on 04/17/24 | 86.45 on 04/17/24 | 131.31 on 03/20/24 |
| High | 0.0600 on 04/15/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 3-Month | |||||
| %Chg | -30.81% since 01/17/24 | +1.48% since 01/17/24 | +4.26% since 01/17/24 | +18.18% since 01/17/24 | +6.70% since 01/17/24 |
| Low | 0.0301 on 02/12/24 | 534.24 on 02/01/24 | 362.14 on 01/24/24 | 71.92 on 01/25/24 | 113.05 on 02/28/24 |
| High | 0.0643 on 01/18/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | -17.81% since 10/17/23 | +12.89% since 10/17/23 | +35.88% since 10/17/23 | +24.04% since 10/17/23 | +66.31% since 10/17/23 |
| Low | 0.0301 on 02/12/24 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 80.93 on 10/26/23 |
| High | 0.0790 on 11/21/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,423 | 211,679,488 | 134,176,672 | 54,203,528 | 52,630,512 |
| Shares Outstanding, K | 100,084 | 381,714 | 354,449 | 601,927 | 385,515 |
| Annual Sales | 70,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -15,180,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 0 | 10,886,000,000 | 1,928,300,000 | 1,534,100,000 | 1,034,500,000 |
| Last Quarter Net Income | -2,260,000 | 1,630,000,000 | 606,200,000 | 369,900,000 | 256,300,000 |
| 60-Month Beta | 1.13 | 0.80 | 1.36 | 1.05 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/14/23 | 5.67 on 01/31/24 | 1.60 on 01/23/24 | 0.64 on 02/06/24 | 0.50 on 02/08/24 |
| Latest Earnings Date | 05/09/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.90 | 83.49 | 35.54 | 89.11 |